Fold change of mRNA expression in lungs of steroid-treated mice
| Control group | TDI group | TDI+prednisone group | TDI+fluticasone propionate group | |
| Ccl11 | 1.00±0.26 | 7.85±2.22** | 7.21±2.27 | 6.28±2.52 |
| Clca3 | 1.00±0.12 | 41.45±8.52** | 47.30±11.95 | 35.32±19.47 |
| Cxcl1 | 1.00±0.14 | 8.37±2.99** | 7.57±2.54 | 8.97±3.36 |
| Cxcl3 | 1.00±0.25 | 4.30±1.17** | 7.06±3.64 | 7.50±3.65 |
| Csf3 | 1.00±0.35 | 18.15±4.22** | 32.99±12.71 | 32.91±11.33 |
| Il17a | 1.00±0.42 | 28.71±4.68** | 33.59±5.78 | 35.18±5.65 |
| Il17f | 1.00±0.09 | 2.61±0.72* | 2.68±0.76 | 2.12±0.46 |
mRNA expression was normalised to control values; data are presented as mean±sd fold change. *: p<0.05; **: p<0.01, compared with the control group. No significant differences were observed between the toluene diisocyanate (TDI) group and the TDI+prednisone group or between the TDI group and the TDI+fluticasone propionate group.